Therapeutics for MS Progression and Progressive Forms of MS
National Multiple Sclerosis Society
UM Funding ID
FD03820
Sponsor
National Multiple Sclerosis Society
Category
International
Description
This fund supports research partnerships with the Society’s commercial development program, Fast Forward, LLC, to accelerate and support development of therapeutic strategies specifically relevant to the Roadmap priority of addressing MS progression and progressive forms of MS.
Funding of $800,000 USD available.
VPRI Contact
Michelina Violi
Research Grants Specialist (Health & International)Michelina [dot] .Violi [at] @umanitoba [dot] .ca
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Pre-Application |
| 15-Jan-2025 5:00 pm EST |
Application | 13-Jan-2025 4:30 pm CST | 22-Jan-2025 5:00 pm EST |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.